184 related articles for article (PubMed ID: 20534585)
1. Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis.
Darwech I; Otero JE; Alhawagri MA; Abu-Amer Y
J Biol Chem; 2010 Aug; 285(33):25522-30. PubMed ID: 20534585
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.
Palkowitsch L; Leidner J; Ghosh S; Marienfeld RB
J Biol Chem; 2008 Jan; 283(1):76-86. PubMed ID: 17977820
[TBL] [Abstract][Full Text] [Related]
3. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.
Otero JE; Dai S; Foglia D; Alhawagri M; Vacher J; Pasparakis M; Abu-Amer Y
J Biol Chem; 2008 Sep; 283(36):24546-53. PubMed ID: 18567579
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis.
Zhang Y; Otero JE; Abu-Amer Y
Calcif Tissue Int; 2013 Jul; 93(1):78-85. PubMed ID: 23686246
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
6. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA; Madge LA; May MJ
J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.
Chaisson ML; Branstetter DG; Derry JM; Armstrong AP; Tometsko ME; Takeda K; Akira S; Dougall WC
J Biol Chem; 2004 Dec; 279(52):54841-8. PubMed ID: 15485831
[TBL] [Abstract][Full Text] [Related]
8. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M
J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
10. IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.
Otero JE; Dai S; Alhawagri MA; Darwech I; Abu-Amer Y
J Bone Miner Res; 2010 Jun; 25(6):1282-94. PubMed ID: 20200955
[TBL] [Abstract][Full Text] [Related]
11. Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected].
Tang ED; Inohara N; Wang CY; Nuñez G; Guan KL
J Biol Chem; 2003 Oct; 278(40):38566-70. PubMed ID: 12890679
[TBL] [Abstract][Full Text] [Related]
12. IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
Adli M; Merkhofer E; Cogswell P; Baldwin AS
PLoS One; 2010 Feb; 5(2):e9428. PubMed ID: 20195534
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-induced tyrosine phosphorylation of IKKβ contributes to NF-κB activation.
Rieke C; Papendieck A; Sokolova O; Naumann M
Biol Chem; 2011 Apr; 392(4):387-93. PubMed ID: 21294676
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.
Duplomb L; Baud'huin M; Charrier C; Berreur M; Trichet V; Blanchard F; Heymann D
Endocrinology; 2008 Jul; 149(7):3688-97. PubMed ID: 18403479
[TBL] [Abstract][Full Text] [Related]
16. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S; Hirayama T; Abbas S; Abu-Amer Y
J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
[TBL] [Abstract][Full Text] [Related]
17. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
Bharti AC; Takada Y; Aggarwal BB
J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
[TBL] [Abstract][Full Text] [Related]
18. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
Li ZW; Chu W; Hu Y; Delhase M; Deerinck T; Ellisman M; Johnson R; Karin M
J Exp Med; 1999 Jun; 189(11):1839-45. PubMed ID: 10359587
[TBL] [Abstract][Full Text] [Related]
19. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.
Darwech I; Otero J; Alhawagri M; Dai S; Abu-Amer Y
J Cell Biochem; 2009 Dec; 108(6):1337-45. PubMed ID: 19830703
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
